Steven Reichling, Chief Financial Officer at Accelerate Diagnostics, Inc (AXDX), bought 1,000 shares at $6.92 ($7K) on 2020-03-19, disclosed to the SEC on 2020-03-19.
Open-market purchase of $7k AXDX by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| AXDX | SELL | 2023-02-15 | $3K | — | Filing → |
| AXDX | SELL | 2023-01-17 | $3K | — | Filing → |
| AXDX | BUY | 2022-08-22 | $7K | — | Filing → |